ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2068

Joint Hypermobility Syndrome and Postural Orthostatic Tachycardia Syndrome (HyPOTS)

Artan Kaso and Ali Askari, Rheumatology, University Hospital Case Medical Center, Cleveland, OH

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: Autonomic disorders, fibromyalgia and hypermobility

  • Tweet
  • Email
  • Print
Session Information

Title: Fibromyalgia, Soft Tissue Disorders, Regional and Specific Clinical Pain Syndromes: Research Focus

Session Type: Abstract Submissions (ACR)

Background/Purpose

Joint hypermobility syndrome (JHS) is a chronically disabling disorder manifested as a widespread musculoskeletal pain and/or fatigue, in the presence of generalized joint hypermobility. It is often masquerading as Fibromyalgia or Chronic fatigue syndrome. It is a condition that is often overlooked by clinicians.

Methods

Currently in our clinic, we have observed 25 patients between 22 and 58 yr who were diagnosed with JHS using the Brighton Criteria (1). All of them presented with one or more of these symptoms: chronic fatigue, generalized musculoskeletal pain (arthralgias and myalgias), pre-syncope, palpitations, dizziness caring the diagnosis of fibromyalgia. They do not have any Marfanoid features or certain types of Ehlers-Danlos syndrome or skin involvement.       

Out of 25 patients 16 (64%) had a positive diagnostic tilt table test consistent with the diagnosis of postural orthostatic tachycardia syndrome (POTS), 6 (24%) have not had a tilt table test done yet (financial, non compliance, etc) and 3 (12%) had a negative tilt table test.

  

Patient

Age

Gender

*Symptoms of Autonomic dysfunction

Tilt table test

1

22

F

+

+

2

39

F

+

+

3

38

F

+

+

4

28

F

+

+

5

32

F

+

Not done

6

40

F

+

–

7

37

F

+

+

8

28

F

+

+

9

32

F

+

+

10

48

F

+

–

11

36

F

+

+

12

32

F

+

+

13

38

F

+

+

14

39

F

+

+

15

36

F

+

+

16

35

F

+

–

17

35

F

+

Not done

18

26

F

+

+

19

33

F

+

Not done

20

22

F

+

+

21

36

F

+

Not done

22

33

F

+

+

23

55

F

+

+

24

58

F

+

Not done

25

28

F

+

Not done

* Patient presented with Symptoms of Autonomic dysfunction like, orthostatic hypotension, palpitation, dizziness, passing out, fatigue.

Results

We have noticed that most of these patients are young female with a mean age of 35 with a presentation consistent with fibromyalgia or chronic fatigue syndrome, however further work up showed presence of autonomic dysfunction clinically and confirmed by tilt table test in 64%. By applying standard of care treatment for POTS with fludrocrotison, increasing water and salt intake, using Ted Hose stocking, they showed improvement in their clinical presentation. 

Conclusion

We conclude that there is a selective group of patients with JHS who have autonomic dysfunction which can contribute to the clinical presentations of these patients. These patients frequently are misdiagnosed as having Fibromyalgia or Chronic fatigue syndrome.

We have acronymed this entity “HyPOTS”.  

Potential manifestations of autonomic dysfunction include cardiac dysrhythmias, postural orthostatic tachycardia syndrome, orthostatic hypotension and orthostatic intolerance. Mechanisms leading to such phenomena in JHS patients may include weakened vascular tissue elasticity and impaired peripheral vasoregulation as a consequence of adrenoceptor or neuronal abnormalities (6, 7).

The pathophysiological basis for these symptoms needs to be further explored.

IRB approval for chart review was gained from University Hospital Case Medical Center.


Disclosure:

A. Kaso,
None;

A. Askari,
None.

  • Tweet
  • Email
  • Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/joint-hypermobility-syndrome-and-postural-orthostatic-tachycardia-syndrome-hypots/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology